Justices Won't Consider IP Suit Over Amylin Drug Promos
The U.S. Supreme Court on Monday declined to hear a health consumer advocacy group's copyright infringement case against Amylin Pharmaceuticals Inc. over patient education materials the advocacy group produced for a diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article